Study reveals mixed results for common stimulant in treating binge eating disorder

[Excerpt] Lisdexamfetamine, marketed as Vyvanse, first received approval from the Food and Drug Administration for the treatment of ADHD, “but its ability to also reduce the frequency of binge eating episodes led to its approval for binge eating disorder,” said Morgan James, assistant professor of psychiatry, member of the Rutgers Addiction Research Center at the…

Read More

Optimizing ADHD treatment: Revealing key components of cognitive–behavioral therapy

[Excerpt] While CBT can provide long-term tools for coping with the challenges of ADHD, it is a complex intervention with many different components. Could some components in CBT be consistently more effective than others? To answer this question, a research team from Japan conducted an extensive review and meta-analysis of existing literature on the subject.

Read More